282 filings
8-K
GILD
Gilead Sciences, Inc.
9 May 24
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
GILD
Gilead Sciences, Inc.
25 Apr 24
Gilead Sciences Announces First Quarter 2024 Financial Results
4:04pm
8-K
GILD
Gilead Sciences, Inc.
22 Mar 24
Gilead Sciences Announces Completion of Acquisition of Cymabay
9:21am
8-K
GILD
Gilead Sciences, Inc.
14 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
GILD
Gilead Sciences, Inc.
12 Feb 24
Entry into a Material Definitive Agreement
8:37am
8-K
2pdd 1tf7spfks
6 Feb 24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
4:04pm
8-K
x0i5op6e5l1zz w6jz
2 Feb 24
Ted Love, MD, Joins Gilead Sciences’ Board of Directors
4:20pm
8-K
arjyf4
7 Nov 23
Gilead Sciences Announces Third Quarter 2023 Financial Results
4:03pm
8-K
tpor2un0ih
14 Sep 23
Entry into a Material Definitive Agreement
9:00am
8-K
49n3q8
16 Aug 23
Regulation FD Disclosure
5:19pm
8-K
31ai2c3 s9b3thyuxlx
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
8-K
9fnpn43
5 May 23
Departure of Directors or Certain Officers
11:15am
8-K
p885eudnj9midowdotoj
27 Apr 23
Gilead Sciences Announces First Quarter 2023 Financial Results
4:05pm
8-K
jvyvq
6 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
20576m7o
2 Feb 23
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
8-K
drfnq43xnwd4ej8to
27 Oct 22
Gilead Sciences Announces Third Quarter 2022 Financial Results
4:04pm
8-K
7oh32d5 itfdx
12 Sep 22
Regulation FD Disclosure
8:00am
8-K
76zk7x
2 Aug 22
Gilead Sciences Announces Second Quarter 2022 Financial Results
4:05pm
8-K
709 jlke7
28 Jul 22
Departure of Directors or Certain Officers
4:01pm
8-K
027i0 07fbwho5n7cmza
31 May 22
Departure of Directors or Certain Officers
4:01pm